Newbridge Financial Services Group, Inc. Bio Rad Laboratories, Inc. Transaction History

Newbridge Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	SELL	$412.59 - $563.26 $2,475 - $3,379	-6 Reduced 60.0%	4 $2,000
Q1 2022 Apr 26, 2022	SELL	$524.57 - $735.42 $1,049 - $1,470	-2 Reduced 16.67%	10 $6,000
Q4 2021 Jan 19, 2022	BUY	$708.84 - $794.68 $4,253 - $4,768	6 Added 100.0%	12 $9,000
Q1 2021 Sep 07, 2021	BUY	$547.01 - $662.35 $547 - $662	1 Added 20.0%	6 $3,000
Q3 2020 Sep 07, 2021	BUY	$454.43 - $535.6 $2,272 - $2,678	5 New	5 $3,000

459

19.6M

23.2K

37.4K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.1B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.